TickerGuard
Buy Day today: Neutral (63) Broad market participation · major macro event coming up
BEAM

Beam Therapeutics Inc

Healthcare · Biotechnology

27.80$ +5.5% vs. previous close Closing price · As of: Nov 4, 2026

Statements

Income Statement

Beam Therapeutics Inc (BEAM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 0.5 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BEAM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
17 316 7.4 12 14 30 7.5 8.5 9.7 114 32 0.5 156
100 140 85 87 94 101 99 102 110 5.7 11 – –
-83 176 -77 12 14 30 7.5 8.5 9.7 114 32 0.5 156
100 140 85 87 94 101 99 102 110 99 105 95 409
25 43 27 30 27 29 28 27 27 32 34 32 125
25 43 27 117 121 130 127 129 137 132 139 127 534
-108 133 -104 -105 -107 -100 -119 -120 -127 -17 -107 -127 -378
13 12 – 14 12 – – 12 11 11 9.9 7.5 39
-96 144 -99 -91 -97 -90 -109 -102 -113 244 -94 -123 -85
-17 1.4 5.4 0.0 -5.5 – – – – – – – –
-96 143 -99 -91 -97 -90 -109 -102 -113 244 -94 -123 -85
-91 150 -93 -85 -91 -85 -104 -97 -107 250 -89 -117 -63

LTM = last twelve months (sum of the four most recent quarters).

Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?